MedicarePartD.guide

A non-government resource built from CMS public data

Osteoporosis drugs on every 2026 Hawaii Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 8 stand-alone Part D plans in Hawaii cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
Osteoporosis drugs by 2026 Hawaii Part D plan
DrugAARP Medicare Rx Saver from UHC$0.00/moS5921-381Humana Basic Rx Plan$0.40/moS5884-115SilverScript Choice$14.70/moS5601-066Wellcare Value Script$21.60/moS4802-164Wellcare Classic$21.70/moS4802-095Humana Value Rx Plan$51.60/moS5884-212Humana Premier Rx Plan$90.20/moS5884-179AARP Medicare Rx Preferred from UHC$139.20/moS5921-414
alendronategeneric FosamaxTier 2$8.00QL 30/30dTier 2$4.00QL 30/30dTier 1$2.00Tier 1$0.00QL 30/30dTier 1$0.00QL 30/30dTier 1$0.00QL 30/30dTier 1$0.00QL 30/30dTier 1$5.00QL 30/30d
risedronategeneric ActonelNot coveredNot coveredTier 1$2.00QL 1/28dTier 2$3.00QL 1/30dNot coveredNot coveredNot coveredNot covered
ibandronategeneric BonivaTier 316%QL 1/28dTier 323%QL 1/28dTier 1$2.00QL 1/30dTier 2$3.00QL 1/30dTier 325%QL 1/30dTier 320%QL 1/28dTier 3$45.00QL 1/28dTier 317%QL 1/28d
ProliadenosumabNot coveredTier 428%QL 1/180dNot coveredNot coveredNot coveredTier 430%QL 1/180dTier 450%QL 1/180dNot covered
denosumab biosimilarsJubbonti, Ospomyv and othersTier 438%QL 1/180dNot coveredTier 435%QL 1/180dTier 440%QL 1/180dTier 435%QL 1/180dNot coveredNot coveredTier 434%QL 1/180d
EvenityromosozumabNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
ForteoteriparatideNot coveredTier 5PA25%QL 2.24/28dNot coveredNot coveredNot coveredTier 5PA26%QL 2.24/28dTier 5PA33%QL 2.24/28dNot covered
teriparatidegeneric ForteoTier 5PA25%QL 2.48/28dNot coveredTier 5PA25%Tier 5PA25%QL 2.48/28dTier 5PA25%QL 2.48/28dNot coveredNot coveredTier 5PA31%QL 2.48/28d
TymlosabaloparatideNot coveredNot coveredTier 5PA25%Not coveredNot coveredNot coveredNot coveredTier 5PA31%QL 1.56/30d

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.